Skip to main content
. 2020 Mar 11;16(1):e1080. doi: 10.1002/cl2.1080

Table A2.

Per‐study contribution matrix for the network of antihypertensive treatments

NMA treatment effect/study IDs 1 2 3 4 5 6 7 8 9 10 11
Mixed estimates
ACE: BBlocker 10.3307 8.8137 0.014 3.5622 4.3208 24.5731 1.5633 2.7752 0.1198 1.633 3.6652
ACE: CCB 8.5763 22.566 0.015 4.4111 4.3575 7.678 1.5232 3.4642 0.1354 5.06 0.4334
ACE: Diuretic 2.966 28.1532 0.1067 21.3995 0.4694 4.8986 0.2048 4.3415 1.9589 0.51 4.8583
ACE: Placebo 1.9547 5.9190 0.018 3.6018 0.2729 2.9909 1.992 22.5414 1.396 5.13 0.2629
ARB: BBlocker 2.0761 0.1095 0.275 0.0264 5.233 3.1626 6.3872 2.0749 0.4382 1.373 1.7846
ARB: CCB 1.4515 3.4458 0.28 0.2076 4.0937 0.0847 6.8536 1.6732 0.4578 4.785 0.0768
ARB: Diuretic 0.7138 12.4406 0.94 4.3368 0.1391 1.4247 9.6542 1.6096 2.3744 0.245 5.9383
ARB: Placebo 1.1829 2.6439 0.27 0.173 0.0511 2.2164 29.3029 2.785 0.7071 5.405 0.9829
BBlocker: CCB 6.1387 5.253 0.0033 0.3209 19.189 4.1994 0.0411 0.3159 0.0146 2.197 2.7772
BBlocker: Diuretic 3.4497 14.3396 0.195 6.6748 5.26 6.944 1.3269 0.3335 1.2104 1.127 17.0469
BBlocker: Placebo 3.9049 2.5437 0.0025 0.1626 4.412 8.1344 5.0268 6.7234 1.5011 7.585 4.0594
CCB: Diuretic 2.4724 29.5536 0.19 5.6663 3.405 1.4981 1.2703 0.1075 1.3754 4.295 5.7463
CCB: Placebo 2.9389 9.2002 0.005 0.4033 2.9195 2.3524 5.0386 5.8199 1.701 20.38 0.6771
Diuretic: Placebo 0.4631 11.8137 0.2 7.0979 0.0795 0.7936 2.4089 6.1784 6.8192 5.895 3.4892
Indirect estimates
ACE: ARB 4.1417 8.194 0.31 2.5678 0.2111 7.4768 11.0341 6.9973 0.2685 0.135 0.5577
NMA treatment effect/study IDs 12 13 14 15 16 17 18 19 20 21 22
Mixed estimates
ACE: BBlocker 1.7862 0.9888 4.2769 2.673 4.0015 3.3405 2.6568 1.1975 0.3826 17.213 0.102
ACE: CCB 2.2297 4.1373 4.3133 0.062 0.8908 3.3688 3.3164 1.1668 0.4327 19.095 2.767
ACE: Diuretic 2.7944 5.3117 0.4647 0.028 4.4307 0.3629 4.1563 0.1569 6.2576 5.8771 0.283
ACE: Placebo 14.5088 0.1056 0.2701 1.85 3.7802 0.211 21.5798 1.526 4.4594 3.9696 1.65
ARB: BBlocker 1.3355 0.0283 5.1799 34.71 3.4897 4.0457 1.9863 4.8928 1.4 3.5611 16.42
ARB: CCB 1.077 1.5781 4.0521 13.19 1.0817 3.1649 1.6018 5.2501 1.4623 3.2522 40.87
ARB: Diuretic 1.036 7.6843 0.1377 11.59 5.3801 0.1076 1.541 7.3955 7.5852 1.316 16.41
ARB: Placebo 1.7925 1.1644 0.0506 7.640 3.3529 0.0395 2.6662 22.4471 2.2589 2.2608 10.61
BBlocker: CCB 0.2033 2.3306 18.9941 4.091 2.6689 14.8351 0.3024 0.0314 0.0468 12.0214 4.015
BBlocker: Diuretic 0.2147 7.6154 5.2066 2.688 11.2137 4.0665 0.3193 1.0164 3.8665 5.7249 0.15
BBlocker: Placebo 4.3275 1.1495 4.3672 6.785 12.1509 3.411 6.4366 3.8507 4.7953 6.5805 2.09
CCB: Diuretic 0.0692 20.2684 3.3704 0.032 4.6091 2.6324 0.1029 0.9731 4.3937 5.4936 2.465
CCB: Placebo 3.746 4.3218 2.8898 1.743 5.1204 2.2571 5.5716 3.8597 5.4339 6.4603 7.15
Diuretic: Placebo 3.9767 4.7994 0.0787 1.711 11.3410 0.0615 5.9148 1.8453 21.784 0.9058 2.343
Indirect estimates
ACE: ARB 4.5038 1.1364 0.2089 13.29 0.5508 0.1632 6.6988 8.4525 0.8579 8.0201 14.21

Note: Columns refer to studies and rows refer to NMA relative treatment effects. Entries show how much each study contributes to the estimation of NMA relative treatment effects. The table can be downloaded as a .csv file by clicking on “Download per study contribution matrix” in “Configuration.”

Abbreviations: ACE, angiotensin‐converting‐enzyme inhibitors; ARB, angiotensin‐receptor blockers; BBlocker, Beta Blocker; CCB, calcium‐channel blocker.